Xenikos competitorsClear all

Xenikos's top competitors include Pliant Therapeutics, Quellis Biosciences, Vyriad and Sosei Heptares.
Xenikos
Xenikos
Xenikos is a clinical-stage biopharmaceutical company.
Pliant Therapeutics
Pliant Therapeutics
Pliant Therapeutics is a company focused on discovering, developing, and commercializing treatments for fibrotic diseases.
Quellis Biosciences
Quellis Biosciences
Quellis is a biopharmaceutical company focused on discovering new molecules to treat serious rare diseases.
Vyriad
Vyriad
Vyriad is a company that develops a biopharmaceutical platform designed to cure cancer.
Sosei Heptares
Sosei Heptares
Sosei Heptares is an international biopharmaceutical company focused on the design and development of new medicines originating from its proprietary GPCR-targeted StaR technology and structure-based drug design platform capabilities.
Founding Date
Founding Date
2012
Founding Date
2016
Founding Date
2017
Founding Date
2016
Founding Date
1990
Type
Type
Private
Type
Private
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Nijmegen, NL HQ
Locations
South San Francisco, US HQ
Locations
Boston, US HQ
Locations
Rochester, US HQ
Locations
Chiyoda City, JP HQ
Great Abington, GB
London, GB
Employees
Employees
13
Employees
701% increase
Employees
N/A
Employees
21
Employees
163
Alexa Website Rank
Alexa Website Rank
294876
Alexa Website Rank
475294
Alexa Website Rank
N/A
Alexa Website Rank
334586
Alexa Website Rank
338040

Funding

Latest funding round
Latest funding round
$ 30m (about 2 years ago)
Latest funding round
$ 62m (about 2 years ago)
Latest funding round
$ 17m (8 months ago)
Latest funding round
$ 24.4m (9 months ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 37m
Total funding raised
$ 107m
Total funding raised
$ 17m
Total funding raised
$ 24.4m
Total funding raised
$ 65m
For sources of this data, please see the company profile

View company profiles

Pliant Therapeutics
HQ
South San Francisco, US
Employees
70↑ 1% increase

Pliant Therapeutics is a company focused on discovering, developing, and commercializing treatments for fibrotic diseases.

View company
Quellis Biosciences
HQ
Boston, US

Quellis is a biopharmaceutical company focused on discovering new molecules to treat serious rare diseases.

View company
Vyriad
HQ
Rochester, US
Employees
21

Vyriad is a company that develops a biopharmaceutical platform designed to cure cancer.

View company
Sosei Heptares
HQ
Chiyoda City, JP
Employees
163

Sosei Heptares is an international biopharmaceutical company focused on the design and development of new medicines originating from its proprietary GPCR-targeted StaR technology and structure-based drug design platform capabilities.

View company